drugset

drugset / Trial / NCT00469703

Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis

NCT00469703 ↗

Phase 2 Terminated 10 enrolled Winthrop University Hospital Celgene Corporation · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if Thalidomide (Thalomid) is effective in treating patients with chronic pancreatitis.

Timeline

Start: 2005-08
Primary completion: 2007-11
Completion: 2007-11

Outcome

Outcome not reported

Stopped: “Terminated”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Thalidomide	Other / unclassified	—	—

Indications